Loading provider…
Loading provider…
Nephrology Physician in Nashville, TN
NPI: 1295882165Primary Practice Location
VANDERBILT UNIVERSITY MEDICAL CENTER
2200 Childrens Way, Nashville, TN
Primary Employer
Vanderbilt Medical Group
vanderbilthealth.com
HQ Phone
Get MD James's Phone Numberphone_androidMobile
Get MD James's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 104 | 155 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 15 | 15 |
Medicare reimbursement policy for ambulatory blood pressure monitoring: A qualitative analysis of public comments to the Centers for Medicare and Medicaid Services.
Authors: James Byrd
Publication Date: 2019-07-03
Authors: Katherine Cahill, Jessica Devin, Joshua Beckman, John Koethe, Jonathan Brown, Kevin Niswender
Journal: Diabetes Obes Metab
Publication Date: 2022-11-10
The renin-angiotensin-aldosterone system and glucose homeostasis.
Authors: Luther, James Matthew, Brown, Nancy J
Journal: Trends Pharmacol Sci
Publication Date: 2011-08-29
Lead Sponsor: Vanderbilt University Medical Center
Collaborators: National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Intervention / Treatment: DRUG: Placebo oral capsule, DRUG: GSK2256294
Lead Sponsor: University of British Columbia
Collaborators: Canadian Institutes of Health Research (CIHR)
Intervention / Treatment: DRUG: Telmisartan, DRUG: Irbesartan, DRUG: Losartan, DRUG: Valsartan, DRUG: Eprosartan, DRUG: Olmesartan, DRUG: Azilsartan, DRUG: Candesartan
Lead Sponsor: Vanderbilt University
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Brigham and Women's Hospital
Intervention / Treatment: OTHER: Adrenalectomy, DRUG: mineralocorticoid receptor antagonist